Pfizer Number of Shares Shorted

PFE
 Stock
  

USD 49.49  0.08  0.16%   

Pfizer Inc fundamentals help investors to digest information that contributes to Pfizer's financial success or failures. It also enables traders to predict the movement of Pfizer Stock. The fundamental analysis module provides a way to measure Pfizer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pfizer stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Pfizer Number of Shares Shorted Analysis

Pfizer's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
 2019 2021 2022 (projected)
Consolidated Income16.3 B18.75 B17.02 B
Direct Expenses10.22 B30.82 B33.25 B
Shares Shorted 
 = 
Shorted by Public 
by Institutions 
More About Number of Shares Shorted | All Equity Analysis

Current Pfizer Number of Shares Shorted

    
  70.04 M  
Most of Pfizer's fundamental indicators, such as Number of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pfizer Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pfizer Number of Shares Shorted Driver Correlations

Understanding the fundamental principles of building solid financial models for Pfizer is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since Pfizer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pfizer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pfizer's interrelated accounts and indicators.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Compare to competition

Based on the recorded statements, Pfizer Inc has 70.04 M of outstending shares currently sold short by investors. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The number of shares shorted for all United States stocks is significantly lower than that of the firm.

Pfizer Number of Shares Shorted Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pfizer's direct or indirect competition against its Number of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics of similar companies.
Pfizer is currently under evaluation in number of shares shorted category among related companies.

Pfizer Current Valuation Drivers

We derive many important indicators used in calculating different scores of Pfizer from analyzing Pfizer's financial statements. These drivers represent accounts that assess Pfizer's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pfizer's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee236.23 K120.7 K184.29 K122.16 K278.23 K300.19 K
Revenue Per Employee582.55 K580.6 K586.07 K532.4 K1.03 M1.11 M
Average Assets170.91 B170.32 B164.21 B162.39 B146.15 B149.93 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA17.94 B17.76 B23.64 B12.31 B29.27 B23.13 B
Earnings Before Interest Taxes and Depreciation Amortization USD14.1 B18.53 B18.24 B23.67 B21.3 B19.62 B
Earnings before Tax8.34 B12.26 B11.86 B17.66 B20.31 B18.49 B
Average Equity62.17 B62.22 B68.67 B61.66 B55.49 B59.93 B
Enterprise Value239.08 B257.07 B289.8 B266.7 B306.71 B295.03 B
Free Cash Flow14.19 B14.59 B13.63 B9.99 B8.99 B10.72 B
Invested Capital72.89 B78.83 B79.54 B87.01 B78.31 B80.24 B
Invested Capital Average79.13 B77.76 B73.71 B84.26 B75.84 B79.17 B
Market Capitalization197.1 B215.9 B252.32 B216.83 B249.35 B242.51 B
Tangible Asset Value64.52 B67.1 B70.8 B73.47 B66.12 B70.04 B
Working Capital7.83 B10.71 B18.07 B(4.5 B)(4.05 B)(4.16 B)

Pfizer ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pfizer's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pfizer's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Pfizer Fundamentals

About Pfizer Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Currently Active Assets on Macroaxis

Please check Pfizer Piotroski F Score and Pfizer Altman Z Score analysis. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.055
Market Capitalization
278.3 B
Quarterly Revenue Growth YOY
(0.06) 
Return On Assets
0.13
Return On Equity
0.36
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.